| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |